Austco Healthcare Ltd · ASX:AHC

Austco Healthcare — Non-Deal Roadshow (September 2022)

23 slides from Austco Healthcare's roadshow presentation, September 2022

  1. Slide 1: Roadshow Presentation

    ROADSHOW PRESENTATION SEPTEMBER 2022 Clayton Astles Chief Executive Officer Brendan Maher Chief Finance Officer

  2. Slide 2: FY22 Highlights

    FY22 HIGHLIGHTS · Revenue from customers up 15% to $35.9 million · Software and SMA revenues up $0.7 million to $5.1 million Austco Healthcare · Invested in sales and marketing capability across three regions. · Underlying NPAT (excludes grant income) up 14% to $1.7 million · Highest reported order

  3. Slide 3: Strategic Objectives

    3 Austco Healthcare STRATEGIC OBJECTIVES

  4. Slide 4: Revenue Strategies

    4 Austco Healthcare FY23 STRATEGIC PLAN REVENUE STRATEGIES 01 Drive organic revenue growth 02 Growth by acquisition 03 Increase software and SMA revenue Recruit additional sales professionals, focus Target feature rich and software capable resellers Recruit software focused channel partners on USA,

  5. Slide 5: Operational Strategies

    5 Austco Healthcare FY23 STRATEGIC PLAN OPERATIONAL STRATEGIES 01 Improve margins 02 Build brand awareness in growth markets 03 Continue to innovate Transition global distribution from Hong Establish strategic partnerships with market Enhance Built-in RTLS with new functionality Kong to Malaysia lea

  6. Slide 6: Global Presence

    Austco Healthcare Global Presence Regional offices give a local sales presence to pursue opportunities in sophisticated and high value Austco Healthcare markets USA/Canada Europe Singapore Australia / NZ USA, Canada, Australia, New MARKETS MARKETS Europe MARKETS Asia, Middle East MARKETS Latam Zeala

  7. Slide 7: Products

    7 Austco Healthcare PRODUCTS Austco R&D have continued to build new products and features over the last 2 years.

  8. Slide 8: Tacera Communications Platform

    Nurse Call TACERA Telemetry Phones & Pagers COMMUNICATIONS PLATFORM Assignments, Scheduling RTLS Advanced systems no longer need middleware Building Management Healthcare Communications platform is the Systems (BMS) EMR / EHR Communications hub for alarm producing systems Middleware Platform No more

  9. Slide 9: Pulse Software Platform

    9 Austco Healthcare PULSE CARE PULSE MOBILE Alarm and alert management Clinical care & communication Workflow Communications PULSE PULSE REPORTS PULSE MANAGE SOFTWARE Enterprise reporting “Productised” API Management application PLATFORM PULSE ATTEND PULSE ENGAGE* Remote patient monitoring Patient e

  10. Slide 10: New Patient Station

    NEW PATIENT STATION Austco Healthcare Single room controller Alexa-ready: microphone array for voice controlled applications Magnetic connectors for quick-release pendants & handsets Built-in RTLS available Acute- and aged-care markets 10

  11. Slide 11: Built-in RTLS 1-Button Badge

    B U I LT- I N R T L S 1-BUTTON BADGE Paired with staff or residents/patients Austco Healthcare IP rated for water immersion Worn around wrist or as pendant Minimum 7 days battery life Replace badge without removing bracelet 11

  12. Slide 12: Master Station: Workflow

    12 Austco Healthcare MASTER STATION: WORKFLOW Component shortage has affected our older stations New Station Manages alarms Communications hub Will feature clinical workflow

  13. Slide 13: Outlook

    OUTLOOK Highest reported order book at $24.7m Market-leading products through sustained R&D commitment Modern and extensible operating platform Increased Investment in Sales and Marketing Supply chain uncertainty still exists for the business, which will need to be managed throughout FY23, and possi

  14. Slide 14: Supply Chain Challenges

    SUPPLY CHAIN CHALLENGES Supply chain challenges remain and are expected to remain for FY23 and possibly beyond: • To mitigate the risks of supply chain interruptions we have invested in additional inventory • Increases in raw material costs and additional freight costs will continue to test margins,

  15. Slide 15: Financial Performance

    15 Austco Healthcare FINANCIAL PERFORMANCE

  16. Slide 16: Revenue from Customers

    16 Austco Healthcare $40M REVENUE FROM $31.6M $31.2M $35.9M 19.9 CUSTOMERS $30M 14.8 17.3 Revenue from customers increased by 15% to $35.9m for the year compared to the prior comparative period (pcp). This is the highest reported revenue $20M over the last 10 years and was driven by a stronger secon

  17. Slide 17: Open Sales Orders

    17 Austco Healthcare OPEN SALES $30M ORDERS $20M Open Sales Orders represent confirmed contracted orders from customers that have not yet been fulfilled. • Since the beginning of COVID-19 we have observed a material build up in our confirmed orders as site access restrictions and supply chain 24.5 2

  18. Slide 18: Gross Profit and Margin

    18 Austco Healthcare GROSS PROFIT $20M 53.5% AND MARGIN 52.0% 52.5% $18M Gross margin % remained under pressure through FY23 as a result of higher raw material costs $16M as well as higher freight costs. This saw margins drop to 52.5% in FY22 as compared to 53.5% in the prior period. Shortages of so

  19. Slide 19: Underlying Earnings

    19 Austco Healthcare UNDERLYING NPAT UNDERLYING EARNINGS Underlying NPAT is the Reported NPAT less Other Income, which are 1,707 grant proceeds, proceeds from legal settlements and Foreign exchange 1,503 losses. Underlying NPAT increased from $1.5m for FY21 to $1.7m in FY22. 1,065 Unlike in FY21, th

  20. Slide 20: Reported Earnings

    20 Austco Healthcare REPORTED NPAT REPORTED EARNINGS Reported NPAT is $2.3m for FY22 which is down $1.1m from FY21. 3,424 Included in the profit for FY22 was $0.7m of grant Income arising from COVID-19 related stimulus packages received primarily from the USA. 2,504 2,328 Included in the profit for

  21. Slide 21: Cash & Dividend

    21 Austco Healthcare CASH & DIVIDEND Debt Cash Cash on hand remains strong at $7.6m. The Company has an immaterial amount of debt. Cash generated from operating activities of $1.9m assisted in absorbing our 7,770 strategic build up of inventories by $4.1m. 7,628 6,447 Given the continued profitabili

  22. Slide 22: Disclaimer

    22 Austco Healthcare DISCLAIMER This presentation was prepared by Austco Healthcare Limited and was authorised for respective affiliates, associates, shareholders, directors, officers, employees, agents, release by the Board of the Company. representatives and advisers (the Austco Parties) make any

  23. Slide 23: Thank You

    23 Austco Healthcare THANK Clayton Astles CEO & Executive Director Aust: +61 411 531 170 YOU US: +1 416 565 7457 clayton.astles@austco.com Brendan Maher CFO & Company Secretary Aust: +61 439 369 551 brendan.maher@austco.com

Austco Healthcare — Non-Deal Roadshow (September 2022) on 6ix